 |
|
|
Washington Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Cerevast Therapeutics, Inc.
| | | Phone: | (425) 821-1939 | Fax: | (425) 821-9313 | Year Established: | 2009 | Main Contact: | Bradford A. Zakes, President & CEO | | Other Contacts: | Andrew Leo, VP, Quality Anthony J. Alleman, COO Patrick Bobbitt, VP, Clinical Affairs Anthony J. Alleman, VP, Operations Gordon Brandt, M.D., CMO Kendall Stever, CFO Andrew Leo, VP, Quality Mike Rothmeyer, Senior VP, Global Sales and Marketing Gordon Brandt, M.D, CMO Andrew Leo, VP, Quality Mark Moehring, Ph.D., CTO W.J. Tyler, Ph.D., CSO Anthony J. Alleman, COO
| | Company Description | Cerevast Therapeutics is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. This non-invasive treatment is administered with Cerevast’s proprietary ultrasonic headframe called the ClotBustTM-ER, an operator independent device that can be rapidly and easily deployed by virtually any emergency room staff to safely administer the ultrasound energy for SonoLysis therapy. | |
|
|
|
|
|